Kick-start the second day of the event by attending a Discussion Workshop and Breakfast. Running from 08:00 - 09:30, each session will provide an in-depth look into the topics below.

Next Generation Sequencing

Long Read And Short Read Sequencing Workshop – Implications For Sample Preparation, Translational Genomic Research As Well As Data And Bioinformatics Analysis

Panel Moderator: Patrick Descombes, Head of Functional Genomics, Senior R&D Expert, Nestlé Institute of Health Sciences SA

Panellists:

AMIN ALLAHYAR , Postdoc, Developmental Biology and Stem Cell Research,
Hubrecht Institute
 
MASSIMO DELLEDONNE, Professor, Department of Biotechnology,University of Verona
 

Single Cell Analysis

An Atlas Of Human Thymic Development Reveals Single Cell Dynamics Of TCR Repertoire Formation

Presenters:

Mike Stubbington, Staff Computational Biologist, 10X Genomics

Jongeun Park, Wellcome Sanger Institute

Panellists: TBC

Genome Editing & Synthetic Biology

The Advancement Of CRISPR In Discovery And Therapeutic Development: Where Is The Technology Heading And What Are The Requirements From The CRISPR Researchers

Short Presentations On Developing Therapeutics Applications Of Genome Editing (10 mins each)
 
  • Off target analysis -TONI CATHOMEN, Professor and Director, Institute for Transfusion Medicine and Gene Therapy, University of Freiburg

  • Design of gRNA & DNA donor repair templates -LIN WU, Director, Genome Modifi cation Facility,Harvard University

  • Base editing tool development -KRISTINE FREUDE, Associate Professor and Director of BrainStem – Center for Excellence in Neuroscience,University of Copenhagen
 
Pitches By Each Vendor About Current Technology Development (10 mins each)
 
  • Kevin Holden, Head of Science, Synthego Corporation

  • Tom Speedy, Field Application Manager, Synthetic Biology, IDT

  • Senior Representative, Thermo Fisher Scientific
 
Panel Discussion: Where Is The Technology Heading And What Are The Requirements From The CRISPR Researchers (30 mins)
 

Panel Moderator: Emanuela Cuomo, Associate Director, AstraZeneca

Panellists:

Toni Cathomen, Professor and Director, Institute for Transfusion Medicine and Gene Therapy, University of Freiburg

Lin Wu, Director, Genome Modifi cation Facility,
Harvard University
Kristine Freude, Associate Professor and Director of BrainStem – Center for Excellence in Neuroscience, University of Copenhagen

Digital PCR

Circulating Tumour DNA Analysis: Moving Towards Precision Oncology

Table 1:

Assessing Potential In Personalised Medicine And Targeted Drug Monitoring
Moderator: TBC

Table 2:
Standardisation Of Pre-Clinical Diagnostic Testing Within
Digital PCR
Moderator: TBC
 
Panel Moderator: Isaac Garcia-Murillas, Staff Scientist, The Institute of Cancer Research

Presenters:

Tereza Vaclova, Research Scientist, AstraZeneca

Jen Lee, Higher Scientific Officer, The Institute of Cancer Research

Adam Sikorski, Senior Scientist, Inivata